Analyst Research

Report Title Price
Thomson Reuters Stock Report - THORATEC CORPORATION (THOR-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
ValuEngine Detailed Valuation Report for THOR
Provider: ValuEngine, Inc.
$127.00
Buy
Market Edge Equity Research Report
Provider: Market Edge
$10.00
Buy
Thoratec Corporation (THOR) - Medical Equipment - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Thoratec Corporation Issues FY 2012 Guidance In Line With Analysts' Estimates


Wednesday, 8 Feb 2012 04:04pm EST 

Thoratec Corporation announced that for fiscal 2012, it expects revenue to be in the range of $445-$460 million, GAAP net income per diluted share is expected to be in the range of $1.21 to $1.31 and non-GAAP net income per diluted share (EPS) is expected to be in the range of $1.58 to $1.68. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $459 million and EPS of $1.65 for fiscal 2012. 

Latest Developments for Thoratec Corp

Latest Key Developments in Advanced

Company Quote

Thoratec Corp
(THOR.OQ)
31.52
0.55 +1.78%
4:00pm EDT